MLH1 and MSH2 have the highest penetrance for cancer of the MMR genes, approaching cumulative risks of 70-80% for all cancers, whereas penetrance of cancer in males with MSH6 (~40%) and both males and females with PMS2 is much lower (~35%) (71). Here, PMS2 is linked to cancer.